- Home
- IDYA vs GAB Comparison
IDYA vs GAB Comparison
Compare IDYA & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- GAB
- Stock Information
- Founded
- IDYA 2015
- GAB 1986
- Country
- IDYA United States
- GAB United States
- Employees
- IDYA N/A
- GAB N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- GAB Investment Managers
- Sector
- IDYA Health Care
- GAB Finance
- Exchange
- IDYA Nasdaq
- GAB Nasdaq
- Market Cap
- IDYA 2.0B
- GAB 1.8B
- IPO Year
- IDYA 2019
- GAB N/A
- Fundamental
- Price
- IDYA $21.85
- GAB $5.56
- Analyst Decision
- IDYA Strong Buy
- GAB
- Analyst Count
- IDYA 13
- GAB 0
- Target Price
- IDYA $53.67
- GAB N/A
- AVG Volume (30 Days)
- IDYA 972.2K
- GAB 667.8K
- Earning Date
- IDYA 02-13-2025
- GAB 01-01-0001
- Dividend Yield
- IDYA N/A
- GAB 10.91%
- EPS Growth
- IDYA N/A
- GAB N/A
- EPS
- IDYA N/A
- GAB N/A
- Revenue
- IDYA $7,000,000.00
- GAB N/A
- Revenue This Year
- IDYA $111.81
- GAB N/A
- Revenue Next Year
- IDYA $240.55
- GAB N/A
- P/E Ratio
- IDYA N/A
- GAB N/A
- Revenue Growth
- IDYA N/A
- GAB N/A
- 52 Week Low
- IDYA $19.96
- GAB $4.56
- 52 Week High
- IDYA $47.72
- GAB $5.88
- Technical
- Relative Strength Index (RSI)
- IDYA 43.52
- GAB 50.78
- Support Level
- IDYA $19.96
- GAB $5.45
- Resistance Level
- IDYA $21.65
- GAB $5.64
- Average True Range (ATR)
- IDYA 1.09
- GAB 0.07
- MACD
- IDYA -0.07
- GAB 0.00
- Stochastic Oscillator
- IDYA 33.57
- GAB 59.52
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.